Commentary: NHS patients should have a choice of drug for wet age-related macular degeneration, despite pressure from pharma

被引：4
作者：
Hambleton, David [1 ]
机构：
[1] South Tyneside Clin Commissioning Grp, Jarrow, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2017年 / 359卷
关键词：
D O I：
10.1136/bmj.j5013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：1
相关论文
共 3 条
[1]   CCGs face legal threat for offering off-label drug for wet AMD [J].
Cohen, Deborah .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 359
[2]   INVESTIGATION Are the odds shifting against pharma in the fight for cheaper treatment for macular degeneration? [J].
Cohen, Deborah .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 359 :j5016
[3]  
General Medical Council, ALL RES
1